Toward sustainable solid-phase peptide synthesis strategy – in situ Fmoc removal

References

• Al Musaimi, O.; Al Shaer, D.; Albericio, F.; de la Torre, B.G. FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals 2023, 2024 (17), 243. doi:10.3390/ph17020243
   Google Scholar
• Muttenthaler, M.; King, G.F.; Adams, D.J.; Alewood, P.F. Trends in Peptide Drug Discovery. Nat. Rev. Drug Discov. 2021, 20, 309–325.
   PubMed Web of Science ®Google Scholar
• de la Torre, B.G.; Albericio, F. The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 2022, 27, 1075. doi:10.3390/molecules27031075
   PubMed Web of Science ®Google Scholar
• Merrifield, R.B. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149–2154.
   Web of Science ®Google Scholar
• Behrendt, R.; White, P.; Offer, J. Advances in Fmoc Solid-Phase Peptide Synthesis. J. Pept. Sci. 2016, 22, 4–27.
   PubMed Web of Science ®Google Scholar
• Jad Y.E.; El-Faham A.; de la Torre B.G.; Albericio F. Solid-Phase Peptide Synthesis, the State of the Art: Challenges and Opportunities. In Peptide-based Drug Discovery: Challenges and New Therapeutics; Srivastava V., Ed.; Royal Society of Chemistry: 2017; pp. 518–550.
   Google Scholar
• Jaradat, D.M.M. Thirteen Decades of Peptide Synthesis: Key Developments in Solid Phase Peptide Synthesis and Amide Bond Formation Utilized in Peptide Ligation. Amino Acids 2018, 50, 39–68.
   PubMed Web of Science ®Google Scholar
• Bray, B.L. Large-Scale Manufacture of Peptide Therapeutics by Chemical Synthesis. Nat. Rev. Drug Discov. 2003, 2, 587–593.
   PubMed Web of Science ®Google Scholar
• Carbajo, D.; El-Faham, A.; Royo, M.; Albericio, F. Optimized Stepwise Synthesis of the API Liraglutide Using BAL Resin and Pseudoprolines. ACS Omega 2019, 4, 8674–8680.
   PubMed Web of Science ®Google Scholar
• Guryanov, I.; Orlandin, A.; De Paola, I., Viola, A., et al. Copper(II) Lysinate and Pseudoproline Assistance in the Convergent Synthesis of the GLP-1 Receptor Agonists Liraglutide and Semaglutide. Org. Process Res. Dev. 2021, 25, 1598–1611.
   Web of Science ®Google Scholar
• Frederick, M.O.; Boyse, R.A.; Braden, T.M., Calvin, J.R., et al. Kilogram-Scale GMP Manufacture of Tirzepatide Using a Hybrid SPPS/LPPS Approach with Continuous Manufacturing. Org. Process Res. Dev. 2021, 25, 1628–1636.
   Web of Science ®Google Scholar
• Anastas, P.; Eghbali, N. Green Chemistry: Principles and Practice. Chem. Soc. Rev. 2010, 39, 301–312.
   PubMed Web of Science ®Google Scholar
• Al Musaimi, O.; de la Torre, B.G.; Albericio, F. Greening Fmoc/tBu Solid-Phase Peptide Synthesis. Green Chem. 2020, 22, 996–1018.
   Web of Science ®Google Scholar
• Ferrazzano, L.; Corbisiero, D.; Tolomelli, A.; Cabri, W. From Green Innovations in Oligopeptide to Oligonucleotide Sustainable Synthesis: Differences and Synergies in TIDES Chemistry. Green Chem. 2023, 25, 1217–1236.
   Web of Science ®Google Scholar
• Kumar, A.; Sharma, A.; de la Torre, B.G.; Albericio, F. In situ Fmoc Removal – A Sustainable Solid-Phase Peptide Synthesis Approach. Green Chem. 2022, 24, 4887–4896.
   Web of Science ®Google Scholar
• Singh S.K.; Collins J.M. New Developments in Microwave–Assisted Solid Phase Peptide Synthesis. In Peptide Synthesis: Methods and Protocols: Hussein W.M., Skwarczynski M., Toth I., Eds.; New York, NY: Springer US; 2020; p. 95–109.
   Google Scholar
• Collins, J.M.; Singh, S.K.; White, T.A., Cesta, D.J., et al. Total Wash Elimination for Solid Phase Peptide Synthesis. Nat. Commun. 2023, 14, 8168.
   PubMed Web of Science ®Google Scholar
• Board I.N.C. Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for … on the Implementation of Article 12 of the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. UN; 1998.
   Google Scholar
• Kumar, A.; Sharma, A.; de la Torre, B.G.; Albericio, F. Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis. Molecules 2019, 24, 4004.
   PubMed Web of Science ®Google Scholar
• Lopez, J.; Pletscher, S.; Aemissegger, A., Bucher, C., et al. N-Butylpyrrolidinone as Alternative Solvent for Solid-Phase Peptide Synthesis. Org. Process Res. Dev. 2018, 22, 494–503.
   Web of Science ®Google Scholar
• Merrifield, R.B.; Mitchell, A.R.; Clarke, J.E. Detection and Prevention of Urethane Acylation during Solid Phase Peptide Synthesis by Anhydride Methods. J. Org. Chem. 1974, 39, 660–668.
   PubMed Web of Science ®Google Scholar
• Kumar, A.; Alhassan, M.; Lopez, J., Albericio, F., et al. N-Butylpyrrolidinone for Solid-Phase Peptide Synthesis is Environmentally Friendlier and Synthetically Better than DMF. ChemSusChem. 2020, 13, 5288–5294.
   PubMed Web of Science ®Google Scholar
• de la Torre, B.G.; Ramkisson, S.; Albericio, F.; Lopez, J. Refractive Index: The Ultimate Tool for Real-Time Monitoring of Solid-Phase Peptide Synthesis. Greening the Process. Org. Process Res. Dev. 2021, 25, 1047–1053.
   Web of Science ®Google Scholar